10x Genomics, under the leadership of co-founder and CEO Serge Saxonov, PhD, is making a strategic shift towards enhancing customer support and expanding its presence in the biopharma market. Following a prolific year of product launches in 2024, the company is now focusing on promoting its recent
Telehealth companies are making significant strides in the healthcare industry by ramping up their advertising efforts and expanding into more complex areas of medicine. Initially known for providing low-stigma, easily accessible health products, these companies are now venturing into fields such
In a significant development for the scientific community, Bio-Rad Laboratories, Inc., a front-runner in life science research and clinical diagnostics products, unveiled its innovative TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. These advanced kits offer a seamless method for res
Sphere Fluidics has made strides in biotechnology by unveiling its innovative Cyto-Mine® Chroma at the SLAS2025 International Conference and Exhibition recently held in San Diego, California. This cutting-edge iteration of their well-established Cyto-Mine platform is primed to revolutionize
The memorandum to President Trump suggests addressing the significant need for a cohesive strategy to manage biological risks through the establishment of a Unified National Biosafety and Biosecurity Agency. The driving factor behind this proposal is the potential for high-risk laboratory research
Thermo Fisher Scientific is taking bold steps toward revolutionizing drug development through its innovative Accelerator Drug Development program. This strategy aims to streamline the complex process from preclinical stages to commercialization by integrating its contract research organization
3D bioprinting is an innovative technology that promises to revolutionize cancer research and treatment by providing more accurate and complex models of tumor tissue. This advancement is particularly significant in the study of cancers involving the BRCA1 gene. Tumor modeling with 3D bioprinting
The transformative impact of a historic AI infrastructure investment on the drug discovery and healthcare sectors is becoming increasingly evident. This $500 billion investment, spearheaded by Stargate—a collaborative venture between OpenAI, SoftBank, and Oracle—aims to fast-track breakthroughs in p
The field of cell therapy is currently witnessing groundbreaking advancements, particularly in the methods of stem cell collection and the automation of manufacturing processes. These innovations hold the potential to revolutionize the sector by significantly enhancing the efficiency, reliability,
In today's rapidly evolving scientific landscape, groundbreaking innovations are consistently transforming our understanding of the world and pushing the boundaries of what is possible. From space exploration to bioengineering, researchers are uncovering new knowledge and developing
